The Role of Oxytocin in the Second Stage of Labor
Washington University School of Medicine · with University of Michigan · NCT04303702
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Any age listed · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 400
- US sites recruiting
- 1
- Study start
- July 1, 2022
- Record last updated
- January 5, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a randomized controlled trial investigating the utility of oxytocin administration in the second stage of labor.
Being studied: Continue Oxytocin; Discontinue Oxytocin
Conditions: Labor Complication
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Nulliparous pregnant women >/= 37 weeks gestation
- Singleton pregnancies
- Admission for induction of labor or spontaneous labor
Exclusion Criteria
- Multiple gestations
- Multiparous patients
- Patients with major fetal anomalies
- Not on oxytocin at the time of complete cervical dilation
- Patients with fetal head visible at the perineum on diagnosis of complete cervical dilation
- Maternal medical condition that prohibits prolonged second stage
Recruiting US locations
Barnes Jewish Hospital
St Louis, MO 63110
Site contact: Nandini Raghuraman, MD MS · 918-691-7389 · raghuramann@wudosis.wustl.edu
Study contacts (from the official record)
- Nandini Raghuraman, MD MSCI · 9186917389 · nraghuraman@wustl.edu
Similar studies in Missouri
All healthy volunteers studies in Missouri →- RecruitingHealthy volunteersPhase 1
A Study of V132 in Healthy Older Participants (V132-001)
Merck Sharp & Dohme LLC
- Location
- Springfield, MO + 9 other US sites
- Eligibility basics
- Ages 50–75
- RecruitingHealthy volunteersPhase 1
A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)
Merck Sharp & Dohme LLC
- Location
- Springfield, MO + 5 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Kansas City, MO + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- St Louis, MO + 14 other US sites
- Eligibility basics
- Ages 2 mo–1